BioAdaptives, Inc.
BDPT
$0.02
$0.007.83%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 357.14% | -- | -100.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 357.14% | -- | -100.00% | -- |
| Cost of Revenue | -98.67% | -89.81% | -- | -100.00% | 445.45% |
| Gross Profit | 106.50% | 105.26% | -- | -100.00% | -1,376.60% |
| SG&A Expenses | 332.96% | 416.27% | 383.69% | 347.94% | 4.56% |
| Depreciation & Amortization | -- | -- | -- | 100.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.74% | 273.05% | 303.07% | 388.84% | 12.97% |
| Operating Income | -117.97% | -272.27% | -400.20% | -445.79% | -32.21% |
| Income Before Tax | -909.31% | 13.72% | 35.74% | -38.58% | -187.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -909.31% | 13.72% | 35.74% | -38.58% | -187.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -909.31% | 13.72% | 35.74% | -38.58% | -187.02% |
| EBIT | -117.97% | -272.27% | -400.20% | -445.79% | -32.21% |
| EBITDA | -116.74% | -271.60% | -419.21% | -516.64% | -123.26% |
| EPS Basic | -706.52% | 72.92% | 45.23% | -98.41% | -70.37% |
| Normalized Basic EPS | -913.79% | 69.86% | 45.38% | -27.87% | -115.18% |
| EPS Diluted | -706.52% | 72.92% | 45.23% | -98.41% | -70.37% |
| Normalized Diluted EPS | -913.79% | 69.86% | 45.38% | -27.87% | -115.18% |
| Average Basic Shares Outstanding | 24.69% | 219.28% | 17.54% | -30.36% | 68.73% |
| Average Diluted Shares Outstanding | 24.69% | 219.28% | 17.54% | -30.36% | 68.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |